Related Experiment Videos
Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis
S Saint1, S Bent, E Vittinghoff
1Department of Medicine, University of California, San Francisco, School of Medicine.
JAMA
|March 22, 1995
Summary
Antibiotics offer a small but significant benefit for patients experiencing exacerbations of chronic obstructive pulmonary disease (COPD). This improvement in COPD symptoms may be clinically meaningful, particularly for those with lower baseline flow rates.
Area of Science:
- Pulmonary Medicine
- Clinical Pharmacology
Background:
- Exacerbations of chronic obstructive pulmonary disease (COPD) significantly impact patient morbidity and healthcare costs.
- Antibiotic therapy is frequently used to treat bacterial infections during COPD exacerbations, but its overall effectiveness requires precise evaluation.
Purpose of the Study:
- To conduct a meta-analysis of randomized controlled trials (RCTs) to determine the efficacy of antibiotic treatment for COPD exacerbations.
Main Methods:
- A systematic literature search was performed using MEDLINE and other databases for English-language RCTs published between 1955 and 1994.
- Studies were included if they involved patients with COPD exacerbations, compared antibiotics to placebo, and provided sufficient data for effect size calculation.
- Data extraction and analysis were conducted independently by researchers.
Main Results:
- The meta-analysis of nine trials showed a small, statistically significant benefit of antibiotics (effect size = 0.22; 95% CI, 0.10 to 0.34).
- Analysis of six studies focusing on peak expiratory flow rate (PEFR) changes also favored antibiotic treatment (effect size = 0.19; 95% CI, 0.03 to 0.35), with an average PEFR increase of 10.75 L/min.
- Sensitivity analyses confirmed the robustness of these findings.
Conclusions:
- Antibiotic therapy provides a small but statistically significant improvement in outcomes for patients with COPD exacerbations.
- The observed clinical improvement may be particularly relevant for patients presenting with reduced baseline lung function.